Literature DB >> 20529684

Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.

Stephen A Kolodziej1, Susan L Hockerman, Terri L Boehm, Jeffery N Carroll, Gary A DeCrescenzo, Joseph J McDonald, Debbie A Mischke, Grace E Munie, Theresa R Fletcher, Joseph G Rico, Nathan W Stehle, Craig Swearingen, Daniel P Becker.   

Abstract

A series of phenyl piperidine alpha-sulfone hydroxamate derivatives has been prepared utilizing a combination of solution-phase and resin-bound library technologies to afford compounds that are potent and highly selective for MMP-13, are dual-sparing of MMP-1 and MMP-14 (MT1-MMP) and exhibit oral bioavailability in rats. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20529684     DOI: 10.1016/j.bmcl.2010.04.130

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

Review 1.  Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.

Authors:  Haoqian Zhang; Mayland Chang; Christopher N Hansen; D Michele Basso; Linda J Noble-Haeusslein
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.